Lower omicron efficacy delayed FDA review on Pfizer shot in kids under 5
February 18, 2022 at 09:29 AM EST
U.S. health regulators delayed their review of Pfizer Inc.'s Covid-19 vaccine in children under 5 years old because the initial two-dose series so far wasn't working well against the Omicron variant during testing, people familiar with the decision said.
